All In Biotech

Drug Trial Radar · NCT04527991

Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Subjects With Metastatic or Locally Advanced Unresectable Urothelial Cancer

Last checked: Nov 19, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 711 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

711

Actual

Start

Jan 13, 2021

Primary completion

Jul 4, 2025

Study completion Jul 4, 2025

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
First posted
Aug 27, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to assess overall survival (OS) with sacituzumab govitecan-hziy in comparison with treatment of physician's choice (TPC) in participants with metastatic or locally advanced unresectable urothelial cancer (UC).

Conditions

  • Locally Advanced or Metastatic Unresectable Urothelial Cancer

Interventions

  • Sacituzumab Govitecan-hziyDrug

    Administered intravenously

  • PaclitaxelDrug

    Administered intravenously

  • DocetaxelDrug

    Administered intravenously

  • VinflunineDrug

    Administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: Up to 42 months

Locations

234 sites in 27 countries. Site status is shown where the registry gives one.

  • Mayo Clinic - Arizona

    Phoenix, Arizona

  • UCLA Hematology/ Oncology

    Los Angeles, California

  • University of California Irvine (UCIMC)

    Orange, California

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

  • Baptist MD Anderson Cancer Center

    Jacksonville, Florida

  • Boca Raton Clinical Research Global USA - Plantation

    Plantation, Florida

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • University of Maryland School of Medicine

    Baltimore, Maryland

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Roswell Park Cancer Institute

    Buffalo, New York

  • Weill Cornell Medical College

    New York, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • Oklahoma Cancer Specialists and Research Institute (OCSRI)

    Tulsa, Oklahoma

  • Penn State Hershey Cancer Institute

    Hershey, Pennsylvania

  • Thompson Oncology Group - Knoxville Downtown

    Knoxville, Tennessee

  • University Cancer Specialists - Knoxville

    Knoxville, Tennessee

  • Harold C. Simmons Comprehensive Cancer Center

    Dallas, Texas

  • Center for Cancer and Blood Disorders

    Fort Worth, Texas

  • Seattle Cancer Care Alliance (SCCA)

    Seattle, Washington

  • Summit Cancer Centers

    Spokane, Washington

  • Chris O'Brien Lifehouse

    North Ryde, New South Wales, Australia

  • Calvary Mater Newcastle

    Waratah, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Icon Cancer Centre Wesley

    Auchenflower, Queensland, Australia

  • Southern Adelaide Local Health Network Incorporated

    Bedford Park, South Australia, Australia

  • Ashford Cancer Centre Research - ICON Cancer Centre Adelaide

    Kurralta Park, South Australia, Australia

  • ICON Cancer Centre Hobart

    Hobart, Tasmania, Australia

  • Monash Health

    Clayton, Victoria, Australia

  • Austin Health

    Heidelberg, Victoria, Australia

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, Australia

  • Sunshine Hospital

    Saint Albans, Victoria, Australia

  • Liverpool Hospital

    Nedlands, Western Australia, Australia

  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, Australia

  • Universitätsklinik für Innere Medizin Graz

    Graz, Austria

  • Ordensklinikum Linz GmbH Barmherzige Schwestern

    Linz, Austria

  • Krankenhaus Der Barmherzigen Bruder Wien

    Vienna, Austria

  • Grand Hôpital De Charleroi - Notre Dame

    Charleroi, Belgium

  • Az Maria Middelares Ghent

    Ghent, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

Showing 40 of 234 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.